Liver Transplant
University of Padua reports research in liver transplant
Published in Hematology Week, August 18th, 2008
"Twenty-five patients received nifedipine (group A), and 25 received carvedilol (group B). Patients were defined as intolerant to nifedipine or carvedilol if severe adverse effects developed. These patients stopped the first drug and were switched to the other one. Patients were defined as full responders to monotherapy if there was normalization of blood pressure, and they were defined as partial...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
Source: Hematology Week (2008-08-18)
More Articles from Hematology Week
- American Association for Cancer Research
Lab study shows methadone breaks resistance in untreatable forms of leukemia - JAMA and Archives Journals
Growth hormone treatment for HIV patients improves abdominal fat, but worsens glucose level - Massachusetts General Hospital
Growth hormone reduces abdominal fat, cardiovascular risk in HIV patients on antiviral therapy - University of Utah Health Sciences
Key site in iron metabolism aids in diagnosing anemia of chronic disease - Acute Pancreatitis
Research from Shanghai Jiao Tong University in the area of acute pancreatitis published - Acute Pancreatitis
Studies from T. Decampos et al in the area of acute pancreatitis described - More from this issue of Hematology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
